Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia" AMERICAN JOURNAL OF HEMATOLOGY Strauss, W. E., Adkinson, N., Macdougall, I. C., Auerbach, M., Kaper, R. F., Chertow, G. M., Krop, J. S. 2018; 93 (9): E232–E233
View details for PubMedID 30016554